Mindbody acquires app developer HealCode
MindBody, a San Luis Obispo-based developer of merchant processing software for yoga and fitness studios, acquired Austin, Texas–based HealCode, which develops web and mobile apps for holistic health service companies. MindBody and HealCode worked closely together previously and about 7,500 of MindBody’s 55,000 subscribers already used HealCode widgets in MindBody software for things like client Read More →
Cottage/Sansum merger could drive up cost of care
It was around 3 a.m. when Emily awoke in a cold sweat. She was short of breath as her fever reached 103 degrees in the midst of an asthma attack. Emily, whose real name has been changed to protect her identity, drove to Santa Barbara Cottage Hospital where she underwent a series of tests. Read More →
FDA approves Amgen’s Blincyto
The U.S. Food and Drug Administration approved Amgen’s drug Blincyto for treating pediatric leukemia patients Sept. 1. In Dec. 2014, the FDA approved Blincyto to treat patients with precursor B-cell acute lymphoblastic leukemia, which is a rare form of the disease. On Sept. 1, the agency extended Blincyto’s approval to include pediatric patients with another Read More →
FDA approves biosimilar of Amgen’s Enbrel
The U.S. Food and Drug Administration formally approved a competing biosimilar of Amgen’s top-selling drug Enbrel on Aug. 30. Made by Switzerland-based Novartis, Erelzi mimics the effects of Enbrel. Enbrel, which was first approved in 1998, is approved to treat rheumatoid arthritis and other conditions by decreasing the amount of a protein produced by the Read More →
Amgen reports positive results for Prolia
Thousand Oaks-based biotech giant Amgen announced positive results from patients receiving Prolia to treat inflammation Aug. 29. In the study, Prolia, normally used to treat osteoporosis, hypercalcemia and bone cancer, was used to treat inflammation. The two-year study enrolled 795 patients to evaluate the safety of two 60 milligram doses of Prolia given under the Read More →
Santa Barbara clinic tackles opioid abuse epidemic
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen alumni start their own biotech companies
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
